People: Aveo Pharmaceuticals Inc (AVEO.O)

AVEO.O on Nasdaq

2.00USD
28 May 2015
Change (% chg)

$-0.16 (-7.41%)
Prev Close
$2.16
Open
$2.12
Day's High
$2.13
Day's Low
$1.97
Volume
2,498,213
Avg. Vol
3,489,267
52-wk High
$3.50
52-wk Low
$0.61

Search Stocks

Kucherlapati, Raju 

Dr. Raju S. Kucherlapati, Ph.D. is an Independent Director of AVEO Pharmaceuticals Inc., since October 2001. He has been a professor of Medicine at Harvard Medical School since 2001 and served as Scientific Director of the Harvard Medical School-Partners HealthCare Center for Genetics and Genomics from 2001 to 2008. Dr. Kucherlapati was a founder of Cell Genesys, Inc., a biopharmaceutical company, Abgenix, Inc., a life sciences company, and Millennium Pharmaceuticals, and currently serves on the board of Enlight Biosciences LLC, a privately held drug discovery and development technologies company, Metamark Genetics, and KEW Group Inc., a privately held personalized oncology company. During the last five years, Dr. Kucherlapati has served as a member of the board of directors at Millennium Pharmaceuticals and Abgenix. Dr. Kucherlapati holds a B.S. in Biology from P.R. College, Kakinada, India, a M.S. in Biology from Andhra University, Waltair, India and a Ph.D. from the University of Illinois at Urbana.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks